Business Development For The Biotechnology And Pharmaceutical Industry


Business Development For The Biotechnology And Pharmaceutical Industry
DOWNLOAD

Download Business Development For The Biotechnology And Pharmaceutical Industry PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Business Development For The Biotechnology And Pharmaceutical Industry book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page





Business Development For The Biotechnology And Pharmaceutical Industry


Business Development For The Biotechnology And Pharmaceutical Industry
DOWNLOAD

Author : Martin Austin
language : en
Publisher: CRC Press
Release Date : 2016-04-08

Business Development For The Biotechnology And Pharmaceutical Industry written by Martin Austin and has been published by CRC Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-04-08 with Business & Economics categories.


Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.



Business Modeling For Life Science And Biotech Companies


Business Modeling For Life Science And Biotech Companies
DOWNLOAD

Author : Alberto Onetti
language : en
Publisher: Routledge
Release Date : 2014-03-21

Business Modeling For Life Science And Biotech Companies written by Alberto Onetti and has been published by Routledge this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-03-21 with Business & Economics categories.


Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.



Best Practices In Biotechnology Business Development


Best Practices In Biotechnology Business Development
DOWNLOAD

Author : Yali Friedman
language : en
Publisher:
Release Date : 2008

Best Practices In Biotechnology Business Development written by Yali Friedman and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2008 with Business & Economics categories.


The mainstream of today's biotechnology companies are small- and medium-sized companies. Only 10 per cent of European biotechnology companies have more than 50 employees, and over half employ less than 20 people. Nearly 70 per cent of Swedish biotechnology companies employ fewer than 10 people. 2 The fundamental origin of most biotechnology companies come from the academia in the form of spin-off companies, via Technology-Transfer Offices. Another source of biotechnology companies is science parks and business incubators, where the goal of incubators is to decrease the chance that a start-up will fail, and shorten the time and reduce the cost of establishing and growing its business. The present work by Yali Friedman is set out to bring together a set of best practices to be used as a framework upon which to understand critical issues in biotechnology business development. Eleven chapters, covering vital aspects of valuation, licensing, cash flow, pharmacoeconomics, market selection, communication and intellectual property (IP) rights, seek to nurture the hungry minds of scientists, business developers and bioentrepreneurs alike.



The Business Of Bioscience


The Business Of Bioscience
DOWNLOAD

Author : Craig D. Shimasaki
language : en
Publisher: Springer Science & Business Media
Release Date : 2009-09-18

The Business Of Bioscience written by Craig D. Shimasaki and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009-09-18 with Medical categories.


My journey into this fascinating field of biotechnology started about 26 years ago at a small biotechnology company in South San Francisco called Genentech. I was very fortunate to work for the company that begat the biotech industry during its formative years. This experience established a solid foundation from which I could grow in both the science and business of biotechnology. After my fourth year of working on Oyster Point Boulevard, a close friend and colleague left Genentech to join a start-up biotechnology company. Later, he approached me to leave and join him in of all places – Oklahoma. He persisted for at least a year before I seriously considered his proposal. After listening to their plans, the opportunity suddenly became more and more intriguing. Finally, I took the plunge and joined this ent- preneurial team in cofounding and growing a start-up biotechnology company. Making that fateful decision to leave the security of a larger company was extremely difficult, but it turned out to be the beginning of an entrepreneurial career that forever changed how I viewed the biotechnology industry. Since that time, I have been fortunate to have cofounded two other biotechnology com- nies and even participated in taking one of them public. During my career in these start-ups, I held a variety of positions, from directing the science, operations, regulatory, and marketing components, to subsequently becoming CEO.



Innovation And Commercialisation In The Biopharmaceutical Industry


Innovation And Commercialisation In The Biopharmaceutical Industry
DOWNLOAD

Author : Bruce Rasmussen
language : en
Publisher: Edward Elgar Publishing
Release Date : 2010-01-01

Innovation And Commercialisation In The Biopharmaceutical Industry written by Bruce Rasmussen and has been published by Edward Elgar Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010-01-01 with Business & Economics categories.


The processes of discovery, testing and distribution of new medicines have undergone radical change in recent decades, from a focus on small molecule drugs to biomedicine and related technologies. Bruce Rasmussen very effectively draws upon modern theories of the firm, data analysis, and case studies to provide important insights into the consequences of this change. He offers convincing evidence that contradicts the widely-held view that the biopharmaceutical sector has not generated considerable economic value. Frank R. Lichtenberg, Columbia University, US Bio- and pharmaceutical industry discovery is a distressed asset today. Why? Bruce Rasmussen s book is a timely and very informative work, building on rich data sources and extensive economic research, on a subject of concern to us all. Is medicine discovery in permanent decline? Are the biotechnology and traditional pharma groups on a collision course, will the traditional group absorb the new, will integration take place, will a new discovery model emerge? I commend Bruce s book to all who wish to understand what is happening. David W. Anstice, Merck & Co., Inc. This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book. The author shows that while traditional pharmaceutical companies have successfully adjusted their business models to meet the challenges of biotechnology, biopharmaceutical start-ups have experienced more problems. Despite the poor financial performance of the vast majority of these firms, the biopharmaceutical sector as a whole has created significant value. However, this has been captured disproportionately by a handful of large, fully-integrated biopharmaceutical firms and, to a lesser extent, by the largest dozen pharmaceutical companies. This highly focused book will be a captivating read for innovation and biopharmaceutical industry analysts, as well as advisers formulating policies to support the development of the biopharmaceutical sector. Academics working on innovation and biotechnology, as well as scientists engaged in research in the life sciences, will also find this book of particular interest.



From Breakthrough To Blockbuster


From Breakthrough To Blockbuster
DOWNLOAD

Author : Donald L. Drakeman
language : en
Publisher: Oxford University Press
Release Date : 2022

From Breakthrough To Blockbuster written by Donald L. Drakeman and has been published by Oxford University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2022 with Biotechnology industries categories.


"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--



Career Opportunities In Biotechnology And Drug Development


Career Opportunities In Biotechnology And Drug Development
DOWNLOAD

Author : Toby Freedman
language : en
Publisher: CSHL Press
Release Date : 2008

Career Opportunities In Biotechnology And Drug Development written by Toby Freedman and has been published by CSHL Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2008 with Biotechnology categories.


An essential guide for students in the life sciences, established researchers, and career counselors, this resource features discussions of job security, future trends, and potential career paths. Even those already working in the industry will find helpful information on how to take advantage of opportunities within their own companies and elsewhere.



Biobusiness


Biobusiness
DOWNLOAD

Author : Gurinder S. Shahi
language : en
Publisher: Lulu.com
Release Date : 2005-06-06

Biobusiness written by Gurinder S. Shahi and has been published by Lulu.com this book supported file pdf, txt, epub, kindle and other format this book has been release on 2005-06-06 with Business & Economics categories.


Compiled and adapted from completed assignments produced by USC graduate students participating in the inter-disciplinary course, "BioBusiness: A Strategic Perspective" (GSBA-599, Spring 2005), offered by the Marshall School of Business, University of Southern California.



Biotechnology Entrepreneurship


Biotechnology Entrepreneurship
DOWNLOAD

Author : Craig Shimasaki
language : en
Publisher: Academic Press
Release Date : 2014-04-08

Biotechnology Entrepreneurship written by Craig Shimasaki and has been published by Academic Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-04-08 with Medical categories.


As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts



Biotechnology Deals


Biotechnology Deals
DOWNLOAD

Author :
language : en
Publisher:
Release Date : 2005

Biotechnology Deals written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2005 with Biotechnology industries categories.


Inside the Minds: Biotechnology Deals is an authoritative, insider's perspective on the issues surrounding biotech deals, including mergers and acquisitions, collaborations, and the future of doing successful deals. Featuring lawyers, CEOs of funded biotech companies, and venture capitalists who invest in them, this book provides a broad, yet comprehensive overview of the art of doing successful deals from the experts themselves. From finding and capitalizing on opportunities to completing the deal, these authors articulate the finer points around doing biotech deals now and what will hold true into the future. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today as experts offer up their thoughts around the keys to success within this fascinating area.About Inside the Minds:Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book.This book is by: Lee R. Brettman, M.D., FACP, Dynogen Pharmaceuticals, Inc.??Successful Strategies for Biotech Deals?Manish N Chapekar, Montreux Equity Partners??Building Successful Biotech Deals?Daniel Devine, Acceptys, Inc.??The Art of the Deal?Mark I. Gruhin, Schmeltzer, Aptaker & Shepard, PC??Mergers and Acquisitions, Collaborations, and Partnerships?James T. Gunton, NJTC Venture Fund??Strategies for Successful Deals?Johnny Humphreys, Gen Prime??Finding Success in Biotech?Roland H. Johnson, Piedmont Pharmaceuticals LLC??Making Your Way Through Biotech Dealings?Thomas G. Klopack, Self Employed, Former CEO of Aclara Biosciences??Keys to Success in Biotechnology?Gerard J. McGarrity, Ph.D., Intronn Inc.??Successful Biotech Deals?Mark Schwartz , Ph.D., Bayhill Therapeutics??Biotech Deal Strategies?Abhi-Shek Jain, WTP Capital, LLC??Secrets to Success?Alexis V. Lukianov, NuVasive, Inc.??Finding and Capitalizing on Opportunities?